CompoAtlas

Immunart

Natural health product licensed in Canada

Licence holder
Suppléments Aromatik Inc.
NPN or DIN-HM
80031736
Status
Inactive licence
Licence date
25 April 2012
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Glycyrrhiza glabra

Source : Racine

Extraction ratio : 4:1

Dry plant equivalent : 200 mg

50 mgNot calculated
Astragalus membranaceus

Source : Racine

Extraction ratio : 1:10

Dry plant equivalent : 250 mg

2.5 mLNot calculated
Echinacée purpurea

Source : Racine

Extraction ratio : 1:5

Dry plant equivalent : 500 mg

2.5 mLNot calculated

Non-medicinal ingredients

Jus de pomme concentré, Saveur naturelle de fraise, Eau purifiée, sucre inverti, Benzoate de sodium, Acide citrique, Sorbate de potassium, Gomme de xanthane

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Cuillière(s) à table ; maximum: 1 Cuillière(s) à tableminimum: 3 days ; maximum: 3 days

Uses authorised in Canada

La réglisse est utilisée traditionnellement en phytothérapie comme expectorant pour aider à soulager les affections respiratoires telles que les catarrhes la toux et la bronchite. Aide au maintien des fonctions immunitaires.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80031736

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line